Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACETATE: Low-chloride vs High-chloride Hypertonic Solution for SAH
NCT03204955Phase 1Completed
- Sponsor
- Emory University
- Start
- Jun 2017
- Primary completion
- Sep 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of sodium acetate ringer's injection in subarachnoid hemorrhage (SAH) (2 arms), sponsored by Emory University. Primary endpoint: Difference between serum chloride level on randomization day and the peak afterwards up to 90 days. Started Jun 2017; status: completed.
02
Drugs
sodium acetate ringer's injection
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT03204955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03204955.